Great ape research ban
A great ape research ban, or severe restrictions on the use of non-human great apes in research, is currently in place in the Netherlands, New Zealand, the United Kingdom, Sweden, Germany and Austria. These countries have ruled that chimpanzees, bonobos, gorillas, and orangutans are cognitively so similar to humans that using them as test subjects is unethical. Austria is the only country in the world where experiments on lesser apes, the gibbons, are completely banned too.
New Zealand granted strong protections to five great ape species in 1999, but these protections have not been explicitly recognized as rights. The use of great apes is now forbidden in research, testing or teaching.
The United States is the world's largest user of chimpanzees for biomedical research, with approximately 1,200 individual subjects currently in U.S. labs. On December 15, 2011, US Institute of Medicine (IOM) declared in a report (see report brief) that ‘most current use of chimpanzees for biomedical research is unnecessary’ and recommended to curtail the government funded research on human’s closest relative. Francis Collins, director of the National Institutes of Health (NIH) announced on the same day that he accepted the recommendations and will develop the implementation plan which includes the forming of an expert committee to review all submitted grant applications and projects already underway involving the use of chimpanzees. Furthermore no new grant applications using chimpanzees will be reviewed until further notice. On 21 September 2012, NIH announced that 110 chimpanzees owned by the government will be retired. NIH owes about 500 chimpanzees for research, this move signifies the first step to wind down NIH’s investment in chimpanzee research, according to Francis Collins. Currently housed at the New Iberia Research Center in Louisiana, 10 of the retired chimpanzees will go to the chimpanzee sanctuary Chimp Haven while the rest will go to Texas Biomedical Research Institute in San Antonio. However, concerns over the chimpanzee’s status in the Texas Biomedical Research Institute as ‘research ineligible’ rather than ‘retired’ prompted NIH to reconsider the plan and it announced on 17 October 2012 that as many chimpanzees as possible will be relocated to Chimp Haven by August 2013 and eventually all 110 will move there. On 22 January 2013, a NIH task force released a report calling for the government to retire most of the chimpanzees the U.S. government support. The panel concluded that the animals provide little benefit in biomedical discoveries except in a few disease cases which can be supported by a small population of 50 primates for future research. Other approaches such as genetically altered mice should be developed and refined. On 13 November 2013, US Congress and Senate passed ‘The Chimpanzee Health Improvement, Maintenance and Protection Act’, approve the funding to expand the capacity of Chimp Haven and other chimpanzee sanctuaries thus allow the transfer of almost all of the apes owned by the federal government to live in a more natural and group environment than in the laboratory. The transfer is expected to take five years when all but 50 chimpanzees, which will remain with the NIH, will be ‘retired’. 
On 11 June 2013, the Fish and Wildlife Service proposed to list captive chimpanzees as endangered, matching its existing classification for wild chimpanzees. Until the Fish and Wildlife proposal, chimpanzees were the only species with a split listing that did not also classify captive members of the species as endangered. If the proposal gains final approval, it is unclear what effect it would have on laboratory research.
In January 2014, Merck & Co. announced that the company will not use chimpanzees for research, joining over 20 pharmaceutical companies and contract laboratories that have made the commitment. As the trend continues, it is estimated the remaining non-government owned 1,000 chimpanzees will be retired to sanctuaries around 2020. 
Announcing the UK’s ban in 1986, the British Home Secretary said: "[T]his is a matter of morality. The cognitive and behavioural characteristics and qualities of these animals mean it is unethical to treat them as expendable for research." Britain continues to use other primates in laboratories, such as macaques and marmosets. In 2006 the permanency of the UK ban was questioned by Colin Blakemore, head of the Medical Research Council. Blakemore, while stressing he saw no "immediate need" to lift the ban, argued "that under certain circumstances, such as the emergence of a lethal pandemic virus that only affected the great apes, including man, then experiments on chimps, orang-utans and even gorillas may become necessary." The British Union for the Abolition of Vivisection described Blakemore's stance as "backward-looking." 
On 7 February 2014 the UK Department of Health released a policy paper outlining the ‘3R’ (replacement, refinement and reduction) strategy to reduce animal testing in research and develop in biosciences. Using new non-animal technologies such as tissue engineering, stem cells, noninvasive imaging and mathematical modeling, the press release stated, the benefits will include not only improvement in animal welfare but also reduction in cost for the industry. The latter derives from the potentially higher successful rate using these cutting-edge technologies in early drug development while results from animal studies sometimes fail to duplicate in human.
- Great Ape personhood
- Great Ape Trust
- Declaration on Great Apes
- Great Ape Project
- Project R&R: Release and Restitution for Chimpanzees in U.S. Laboratories
- Animal liberation movement
- Animal testing
- "A STEP AT A TIME: NEW ZEALAND’S PROGRESS TOWARD HOMINID RIGHTS" BY ROWAN TAYLOR
- Federal Bill Introduced to End Invasive Research on Chimpanzees
- "Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity". iom.edu. Institute of Medicine. December 15, 2011. Retrieved December 19, 2011.
- Wadman, Meredity (December 16, 2011). "US Chimpanzee Research to be Curtailed". Nature.com. Retrieved December 19, 2011.
- "Statement by NIH Director Dr. Francis Collins on the Institute of Medicine report addressing the scientific need for the use of chimpanzees in research". National Institutes of Health. December 15, 2011. Retrieved December 19, 2011.
- Greenfieldboyce, Nell (21 September 2012). "Government Officials Retire Chimpanzees From Research". NPR. Retrieved 24 September 2012.
- Lisa Myers and Diane Beasley (17 October 2012). "Goodall praises NIH decision to remove some chimps from research, but controversy erupts over their next home". nbcnews.com. Retrieved 22 October 2012.
- Flinn, Ryan (23 January 2013). "U.S. Panel Calls for Limits on Medical Use of Chimpanzees". Bloomberg.com. Retrieved 15 February 2013.
- Working Group on the Use of Chimpanzees in National Institutes of Health (NIH)-Supported Research (22 January 2013). "Council of Councils Working Group on the Use of Chimpanzees in NIH-Supported Research Report". NIH.
- Dizard, Wilson (15 November 2013). "Federal government to transfer laboratory chimps to sanctuaries". Aljazeera America. Retrieved 3 December 2013.
- Fears, Darryl (11 June 2013). "Fish and Wildlife proposes endangered listing for captive chimpanzees". The Washington Post. Retrieved 12 June 2013.
- The Associated Press (30 January 2014). "Merck joins other drugmakers, contract research labs vowing not to do research on chimpanzees". Associated Press. Retrieved 20 February 2014.
- Press Release (30 January 2014). "Top Pharmaceutical Company Stops Chimpanzee Use in Research". The Humane Society of the United States. Retrieved 20 February 2014.
- Steve Connor (June 3, 2006). "Scientists 'should be allowed to test on apes'". The Independent.
- "Ban all experiments on the higher primates". The Independent. March 28, 2001.
- Helene Guldberg (March 29, 2001). "The great ape debate". Spiked online.
- Mullin, Emily (10 February 2014). "U.K. pledges to reduce use of animals for bioscience research". fiercebiotechresearch.com. Retrieved 4 March 2014.